N@N

Market Maker Surveillance Report. CEMI, SMSI, SVA, HALO, LEI, CTIX, Winning Stocks With Lowest Price Friction For Friday, Dece

December 21, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 4158 companies with "abnormal" market making, 2002 companies with positive Friction Factors and 3683 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Friday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Chembio Diagnostics Inc (NASDAQ:CEMI), Smith Micro Software Inc (NASDAQ:SMSI), Sernova Corp (NASDAQ:SVA), Halozyme Therapeutics Inc (NASDAQ:HALO), Lucas Energy Inc (AMEX:LEI), Cellceutix Corp (OTC:CTIX). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  CEMI    $0.670    14.57%    489,461      50.92%    469,697      48.86%    19,764       295     
  SMSI    $0.300    19.61%    147,843      51.83%    97,255       34.09%    50,588       1,686   
  SVA     $0.470    16.73%    298,673      67.78%    141,602      32.13%    157,071      3,342   
  HALO    $1.490    26.99%    5,047,641    56.00%    3,887,364    43.13%    1,160,277    7,787   
  LEI     $0.160    14.55%    130,005      32.38%    112,308      27.98%    17,697       1,106   
  CTIX    $0.310    19.62%    571,763      46.63%    456,946      37.27%    114,817      3,704   

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows CEMI with a dollar gain Friday of $0.67000 and a Friction Factor of 295 shares. That means that it only took 295 more shares of buying than selling to move CEMI higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

Chembio Diagnostics Inc (NASDAQ:CEMI) - Chembio Diagnostics, Inc., together with its subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, and markets rapid diagnostic tests that detect infectious diseases. The company offers rapid tests for the detection of HIV antibodies, syphilis, and canine leishmaniasis. Its products include Lateral Flow Rapid HIV Tests and DPP HIV Test, which are qualitative Yes/No tests for the detection of antibodies to HIV 1 and 2 with visually interpreted results available within approximately 15 minutes. The company sells its products under its STAT PAK, SURE CHECK, or DPP trademarks, as well as under the private labels of its marketing partners. Chembio Diagnostics sells its products to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. The company has agreements with the Oswaldo Cruz Foundation relating to products based on its DPP technology; Bio-Rad Laboratories N.A. for the development of a six-band multiplex product on its DPP; and Infectious Disease Research Institute for the development and initial supply of a rapid point-of-care test for infectious diseases. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Medford, New York..

Smith Micro Software Inc (NASDAQ:SMSI) - Smith Micro Software, Inc. provides software and services that simplify, secure, and enhance the mobile experience. The company s Wireless segment develops mobile connectivity and communications management solutions, which comprise QuickLink Mobile, a broadband connectivity solution, which enables mobile users to connect personal computer, laptop, or other wireless device to wireless wide area networks, and wireless local area networks or Wi-Fi hotspots; QuickLink Mobility, a mobile VPN and connection management solution for enterprises with mobile workforces; and Experience Manager that enables end-users to manage their broadband connections and data plans across different devices and networks. This segment also provides QuickLink Hotspot Manager, which provides control over the use and sharing of mobile hotspot devices; Mobile Network Director that provides intelligent traffic management for data offload and network transitions between 3G/4G/Wi-Fi; Device Management Suite, which offers automated mobile device provisioning and configuration; Push-To-Talk, a data service that uses a mobile Internet connection to send and receive walkie-talkie style calls; Visual Voicemail and Voice to Text solutions; and Vidio and Vidio XTP for adaptive streaming of video content. Its Productivity and Graphics segment offers StuffIt Deluxe, a solution for documents and media; Poser, a solution for creating 3D character art and animations; Anime Studio, an animation tool for professionals and digital artists; and Manga Studio, a solution for creating manga and comic art. This segment distributes its products through online stores, third-party wholesalers, retailers, and value-added resellers worldwide. The company serves mobile network operators, original equipment manufacturers, device manufacturers, and enterprise businesses. Smith Micro Software, Inc. was founded in 1982 and is headquartered in Aliso Viejo, California..

Sernova Corp (NASDAQ:SVA) - Sinovac Biotech Ltd., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines against the hepatitis A, hepatitis B, and influenza viruses in the People's Republic of China. It offers Healive, an inactivated hepatitis A vaccine; Bilive, a combination of hepatitis A and B vaccine; Anflu, a split virus influenza vaccine; and Panflu, a vaccine against the influenza A H1N1 virus. The company's pipeline vaccine candidates include a split viron vaccine, which completed Phase II clinical trials for the H5N1 influenza virus; and a SARS vaccine, which completed Phase I clinical trials for the SARS virus. In addition, its pipeline vaccine candidates that completed the pre-clinical trials comprise human vaccines for EV71, pneumococcal conjugate, haemophilus influenzae type b, meningitis, Japanese encephalitis, chickenpox, mumps, and rubella diseases, as well as rabies vaccine for humans and animals. The company markets and sells its vaccine products directly to the provincial and municipal disease control and prevention centers. It has a patent license agreement with the National Institutes of Health; distribution agreements with LG Life Sciences, Ltd. and Glovax C.V.; and a pandemic influenza vaccine co-development agreement with the China Center for Disease Control and Prevention. Sinovac Biotech Ltd. was founded in 1999 and is headquartered in Beijing, the People's Republic of China..

Halozyme Therapeutics Inc (NASDAQ:HALO) - Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of products targeting the extracellular matrix for the endocrinology, oncology, dermatology, and drug delivery markets. Its portfolio of products and product candidates is based on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix. The companys Enhanze technology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. It has partnerships with F. Hoffmann-La Roche, Ltd and Hoffmann-La Roche, Inc. to apply Enhanze Technology to Roches biological therapeutic compounds for up to 13 targets; and with Baxter Healthcare Corporation to apply Enhanze Technology to Baxters biological therapeutic compound, GAMMAGARD LIQUID, as well as to develop and supply active pharmaceutical ingredient for HYLENEX, a product used as an adjuvant to increase the dispersion and absorption of other injected drugs and fluids. The company was founded in 1998 and is based in San Diego, California..

Lucas Energy Inc (AMEX:LEI) - Lucas Energy, Inc. operates as an independent oil and gas company in Texas. It has interests in approximately 12,500 gross acres of oil and gas leases in South Texas, primarily in the Gonzales County and Wilson County, Texas. The company also holds oil and gas interests in the Austin Chalk formation, Buda formation, and Eagle Ford Shale formation. In addition, it operates 30 producing wells. The company is based in Houston, Texas..

Cellceutix Corp (OTC:CTIX) - Cellceutix Corporation, a development stage biopharmaceutical company, develops cancer and anti-inflammatory drugs in the United States. The companys lead product candidate includes Kevetrin, which is in pre-clinical development stage primarily for the treatment of head and neck cancers. It is also developing various other product candidates for the treatment of psoriasis, rheumatoid arthritis, osteo-arthritis/asthma, and hypertensive emergency, as well as neurological disorders, such as multiple sclerosis, Lou Gehrig disease, and/or Parkinson's disease. The company was founded in 2007 and is headquartered in Beverly, Massachusetts..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net